# apoQlar · HoloMedicine®
> The spatial AI platform for medicine – 3D, AI and XR in one. Surgical planning, robotic-surgery proctoring and medical education, from the operating room to anywhere in the world.

apoQlar GmbH (Hamburg, Germany) builds HoloMedicine®, a spatial-computing platform for medicine. The HoloMedicine® Patient Viewer is MDR Class IIa certified and FDA 510(k) cleared; the education and proctoring tiers are training/telepresence only and carry no medical-device claim.

## Workflows
- [Clinical](https://apoqlar.com/clinical.html): tumor board and surgical planning in the MDR Class IIa-certified Patient Viewer.
- [Proctoring](https://apoqlar.com/proctoring.html): HoloMedicine® Robotics – live robotic-surgery proctoring in true 3D via XR headsets; advisory-only telepresence, never instrument control.
- [Education](https://apoqlar.com/education.html): plan, record and teach in spatial 3D; no patient data required.
- [Platform](https://apoqlar.com/platform.html): one verified HoloMedicine® ID across every workflow, embedded into hospital infrastructure, with an open XR app ecosystem.

## Published evidence
- Surgical planning – 3D CT/MRI reconstructions improve anatomy interpretation and planning (ScienceDirect).
- 5G robotics – live XR broadcast of robotic surgery at 22 ms latency to 7 countries, powered by HoloMedicine® Robotics (Journal of Robotic Surgery, 2026).
- Education – 70% of students prefer MR-supplemented teaching (ScienceDirect).

## Regulatory
- https://apoqlar.com/regulatory.html – FDA 510(k) cleared, CE Class IIa, certified in 33 countries; ISO 13485 / 14971 / 62304; HIPAA & GDPR.

## Languages
English (default), Deutsch (index.de.html), Español (index.es.html), Chinese site at https://www.holomedicine.cn/

## Contact
apoQlar GmbH, Hamburg, Germany · contact@apoQlar.com